| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 2988.4 | 2360.0 | 2503.1 |
| Other income | 0.4 | 0.6 | 1.4 |
| Total income | 2988.8 | 2360.6 | 2504.5 |
| Profit before exceptional items & tax | 102.3 | 99.5 | 71.9 |
| Profit before tax | 122.9 | 112.5 | 90.5 |
| Net profit | 96.8 | 86.9 | 73.2 |
| Operating margin | 4.1% | 4.8% | 3.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +32.20% |
|---|---|
| Net profit, quarter on quarter | +11.40% |
| Revenue, year on year | +19.40% |
| Operating profit, year on year | +44.50% |
| Operating profit, quarter on quarter | +3.00% |
BSE results filing, NSE: INDIAGLYCO. Figures extracted from the filing.
India Glycols Ltd: key numbers
- Share price
- ₹309.90
- Market cap
- ₹2,077 Cr
- Revenue (annual)
- ₹4,211 Cr
- Net profit (annual)
- ₹292.8 Cr
- P/E (TTM)
- 6.6×Sector 37.5×
- Promoter holding
- 59.63%+0.00% QoQ
- FII holding
- 2.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from India Glycols Ltd
All →India Glycols Board Meeting Outcome
India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.
India Glycols Earnings Call Transcript: Key Takeaways
India Glycols posted a record Q1 with 19% net revenue growth and 32% PAT growth, driven by its Bio-Pharma segment. Management is aggressively pivoting toward a premium-led consumer model through restructuring and new liquor brand partnerships.
India Glycols Investor Presentation: Key Takeaways
India Glycols reported strong Q1FY27 results with 19% Gross Revenue growth and 32% PAT growth, driven by a diversified portfolio and a demerger strategy into three focused platforms.
India Glycols Earnings Call: Key Takeaways
India Glycols reported a strong FY26 with net revenue of ₹4,211cr (up 11.8%) and PAT of ₹293cr (up 26.8%). Strategy focuses on premiumization in spirits and expanding bio-based chemicals.
India Glycols Earnings Call: Key Takeaways
India Glycols delivered solid FY26 performance led by portable spirits and biofuels, successfully deleveraging the balance sheet through promoter equity infusion and internal accruals while shifting toward a premium-led liquor portfolio.
India Glycols Earnings Call: Key Takeaways
India Glycols delivered strong FY26 performance with 11.8% Net Revenue growth and 26.8% PAT growth. Management is executing a three-way demerger into Chemicals, Spirits/Bio-Fuel, and Bio-Pharma entities.